Restaurant Industry: Aug 11 - Australia (5 stories)
Tuesday, 11 Aug 2026 Daily Food & Beverage Australia
Here is your Daily summary for Food & Beverage across Australia for Tue 11th August 2026
JBS Foods Australia has sold a $3.5 billion stake to Danantara, marking a significant move aimed at enhancing Indonesia’s protein sector. This joint venture could reshape the regional market dynamics and strengthen JBS's position in Asia.
In another development, Casella is diversifying its portfolio through two new partnerships, moving beyond its traditional wine base to adapt to changing consumer preferences. This strategy highlights the company's commitment to innovation in a competitive landscape.
Meanwhile, the rise of GLP-1 drugs is stirring debate in the FMCG sector, as these medications reduce appetite and could impact consumer purchasing behavior. Industry experts are assessing whether this trend poses a genuine threat to sales.
Lastly, A.G. Barr has experienced a dip in its stock value due to supply chain issues affecting its first-half sales growth, reflecting ongoing challenges in the food and beverage industry.
Featured Articles
Key stories and insights from this topic
-
JBS Foods Australia sells $3.5bn stake to Danantara
Inside FMCG 10 Aug 2026, 2:57amThe new joint venture hopes to develop Indonesia’s protein sector. The post JBS Foods Australia sells $3.5bn stake to Danantara appeared first on Inside FMCG.
-
A.G. Barr falls to two-month low after supply issues hit H1 sales growth
All News 4 Aug 2026, 8:44am -
Casella expands portfolio with two new partnerships
Inside FMCG 10 Aug 2026, 2:23amThe agreements will see CFB push beyond its wine base and diversify its categories to meet the evolving consumer trends. The post Casella expands portfolio with two new partnerships appeared first on Inside FMCG.
-
Form 8K Where Food Comes From Inc For: 10 August
All News 10 Aug 2026, 5:36pm -
A shrinking problem? How GLP-1 drugs are changing the FMCG basket
Inside FMCG 10 Aug 2026, 7:39amGLP-1 drugs are reducing appetites, but are they really a threat to the FMCG sector? The post A shrinking problem? How GLP-1 drugs are changing the FMCG basket appeared first on Inside FMCG.